|
Shares in Feedback PLC fell sharply on Monday after the company said a key decision from the NHS on a potential large-scale contract has been delayed. The London-based provider of clinical communication platform Bleepa dropped 20% to 11.50 pence in London at midday on Monday. Feedback said it now expects a central NHS decision on a possible nationwide rollout of Bleepa to be delayed by at least six to nine months due to internal factors, pushing any outcome into the 2026-27 financial year. Despite the setback, the company said discussions with NHS stakeholders continue to progress ‘positively’, with potential opportunities aligned to new frontline digitisation funding expected to become available next year. Chief Executive Tom Oakley said: ‘Despite the delay in the NHS’s decision, we remain optimistic of a positive outcome.’ Feedback highlighted continued traction for Bleepa at existing sites, including an extension of its licence at Queen Victoria Hospital NHS Foundation Trust through to December 2026, with an annualised contract value of £495,000. Elsewhere, Feedback confirmed it will not renew a contract with Royal Berkshire NHS Foundation Trust as it refocuses resources on higher-growth Bleepa pathway opportunities. The group also secured a further contract extension with Northern Care Alliance NHS Foundation Trust. Feedback said it remains confident in its medium-term prospects, citing ongoing dialogue with national NHS stakeholders and the potential for its technology to support waitlist reduction and elective recovery targets. The company added that its cash position is ‘carefully managed’ and provides a runway through to mid-2027. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
